tirzepatide ending FDA confirms shortage is still over, gives compounders a grace period tirzepatide shortage ending Eli Lilly's

There is no monthly membership fee, but you do need to factor in the cost of obtaining and maintaining a prescription through a separate provider

Clinicians recommend maintaining a deficit of at least 500 calories per day for effective weight loss, and a total intake of 1,200 - 1,800 calories per day

Provider consultation with genetic and biomarker context enables more informed medication matching

According to the SmPC, the most frequently reported adverse effects of Rybelsus include: Nausea (frequency varies by dose, commonly reported) Diarrhoea Vomiting Abdominal pain Decreased appetite Constipation Dyspepsia (indigestion) These gastrointestinal symptoms are typically most pronounced during treatment initiation and dose escalation, often diminishing over time as the body adjusts to the medication

Purpose-built for physicians GLP-1s tied to a particularly noteworthy decrease in likelihood of a dementia diagnosis Key takeaways: Patients prescribed GLP-1s had up to a 44% reduced likelihood of a dementia diagnosis

Sign up for our Morning Rounds newsletter here